• A new innovative drug1 to better help hemorrhoid and chronic venous disease patients
  • Rapid relief of symptoms thanks to its unique formulation2 (micronization and 5 active flavonoids)
  • Prevention of disease progression thanks to its unique anti-inflammatory and venoprotection mode of action
  • First and unique position3 in international guidelines

Indicated for:
      • Treatment of Hemorrhoidal disease
      • Treatment of Chronic Venous disease

References:
1. Alexander KIRIENKO 1, Djordje RADAK; International Angiology 2016 August;35(4):399-405
2.
Garner RC et al. J Pharm Scl. 2002;91:32-40, Paysant J et al. Int Angiol. 2008;27:81-831
3. 
Adapted from A, Kakkos S, Baekgaard N, et al. Management of chronic venous disorders of the lower limbs. Guidelines according to scientific evidence. Part I. Int Angiol. 2018;37(3):181-254.



References on file. Servier.